Takeda Ordered to Pay $885M in Landmark Pay-for-Delay Lawsuit
A U.S. federal jury ruled that pharmaceutical company Takeda is liable for a pay-for-delay arrangement involving its drug Amitiza, ordering the firm to pay up to $2.5 billion after damages are trebled. The verdict marks the first time a federal jury has found liability in such an antitrust case.
Topics: lawsuits monopoly pay-for-delay pharmaceuticals